MOBILE VIEW  | 

AFRICAN SNAKES-VIPERIDAE

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Venomous snakes continue to exist and thrive in most parts of Africa. This management is limited to the Family VIPERIDAE (ADDERS {genera Bitis and Causus} and VIPERS {genera Atheris, Cerastes, Echis and Vipera}) of most medical importance to this region.
    B) In general, vipers and adders are relatively thick bodied, sluggish, mainly terrestrial snakes which have long, curved, cannulated and fully erectile fangs which fold down against the upper jaw in a layer of mucous membrane when the snake is inactive. Approximately 45 species inhabit the region, including the saw-scaled or carpet vipers (genus Echis) and the puff adder (Bitis arietans) which are considered to be highly venomous to this region (Warrell, 1995).
    C) This region includes the whole continent of Africa including Madagascar and "the Arabian Peninsula" bounded to the north by Syria and the northeast by Iraq. Turkey and Iran and other Asian countries are NOT included and can be found in the management titled: ASIAN SNAKES-VIPERIDAE. Some geographic overlap may occur in this management with venomous snakes of the Middle East. Please refer to the SNAKES, MIDDLE EASTERN management as appropriate.

Specific Substances

    A) VIPERIDAE
    1) Adenorhinos barbouri
    2) Atheris ceratophorus
    3) A. chlorechis
    4) A. desaixi
    5) A. hindii
    6) A. hispidus
    7) A. katangensis
    8) A. laeviceps
    9) A. nitschei
    10) A. squamiger
    11) A. superciliaris
    12) Bitis arietans
    13) B. atropos
    14) B. caudalis
    15) B. cornuta
    16) B. gabonica
    17) B. heraldica
    18) B. inornata
    19) B. nasicornis
    20) B. parviocula
    21) B. peringueyi
    22) B. schneideri
    23) B. worthingtoni
    24) B. xeropaga
    25) Causus bilineatus
    26) C. defilippi
    27) C. lichtensteini
    28) C. maculatus
    29) C. resimus
    30) C. rhombeatus
    31) Cerastes cerastes
    32) C. gasperettii
    33) C. vipera
    34) Echis coloratus
    35) E. leucogaster
    36) E. ocellatus
    37) E. pyramidum
    38) E. sochureki
    39) Pseudocerastes persicus
    40) Proatheris superciliaris
    41) Vipera bornmuelleri
    42) V. latasti
    43) V. (macrovipera) lebetina
    44) v. palaestinae

Available Forms Sources

    A) SOURCES
    1)
    VIPERIDAECOMMON NAME
    Adenorhinos barbouriBarber's bush viper
    Atheris ceratophorushorned or Usambara forest viper
    A. chlorechisWest African or Schlegel's green tree viper
    A. desaixiMount Kenya bush viper
    A. hindiimontane viper
    A. hispidusrough-scaled, prickly or hairy bush viper
    A. katangensis(unreported)
    A. laeviceps(unreported)
    A. nitscheiGreat lakes bush viper
    A. squamigerHallowell's green tree or bush viper
    A. superciliarislowland, swamp or domino-bellied viper
    Bitis arietanspuff adder
    B. atroposberg adder or cape mountain adder
    B. caudalishorned or sidewinding adder
    B. cornutahornsman or many-horned adder
    B. gabonicaGaboon viper or adder
    B. heraldica(unreported)
    B. inornataplain mountain adder
    B. nasicornisrhinoceros-horned or nose-horned viper or river jack
    B. parviocula(unreported)
    B. peringueyiPeringuey's desert or side-winding adder
    B. schneideriNamaqua dwarf adder
    B. worthingtoniKenyan horned viper or Worthington's viper
    B. xeropagadesert mountain adder
    Causus bilineatus(unreported)
    C. deflippisnouted night adder
    C. lictensteiniLichtenstein's or olive night adder
    C. maculatuswestern rhombic night adder
    C. resimusvelvety green night adder
    C. rhombeatuseastern rhombic night adder
    Cerastes cerasteshorned or desert viper
    C. gasperettiiGasperetti's horned or desert viper
    C. viperaSahara desert viper
    Echis coloratusBurton's carpet viper
    E. leucogasterwhite-bellied carpet viper
    E. ocellatusSaw-scaled, Ocellated or West African carpet viper
    E. pyramidumEgyptian carpet viper
    E. sochurekiSochurek's saw-scaled viper
    Proatheris superciliarisLowland swamp viper, East African Lowland viper, Peter's viper, Eyebrow viper, Floodplain viper, Mozambique viper, African lowland viper, domino viper, swamp adder, swamp viper, lowland viper
    Pseudocerastes persicusField's or false-horned viper
    Vipera bornmuelleriBornmueller's viper
    V. latastiLataste's or snub-nosed viper
    V. lebetinaLevantine or blunt-nosed viper
    V. palaestinaePalestine viper

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) USES: This management is limited to the vipers of Africa and the surrounding region of most medical importance. Some geographic overlap may occur in this management with venomous snakes of the Middle East. Please refer to the SNAKES, MIDDLE-EASTERN management as appropriate. There are over 45 species that inhabit this region. In particular, the saw-scaled or carpet vipers (genus Echis), the puff adder (Bitis arietans), and the Gaboon viper (B. gabnonica) are of significant medical importance.
    B) TOXICOLOGY: Snake venom varies in composition and quantity dependent on the species and size of the snake and the mechanical efficiency in which the bite occurred. Clinically important components of venom include proteolytic/procoagulant enzymes, cytolytic/necrotic toxins, hemolytic/myolytic phospholipase A2, neurotoxins, vasodilators and hemorrhagins.
    C) EPIDEMIOLOGY: True epidemiologic data on African snakebites are difficult to ascertain. The World Health Organization estimates 100,000 envenomations and 5,000 deaths from African snakes (including Viperidae and Elapidae) annually in 2010. Because of the inaccuracies of reporting systems, the estimate of the annual incidence is as high as 1,000,000 bites with 500,000 envenomations and 20,000 deaths.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE TOXICITY: LOCAL TISSUE INJURY: An estimated 20% to 50% of snake bites do not result in envenomation - "dry bite". Localized pain and swelling occur after envenomation by most species of vipers; localized bleeding is also relatively common and tissue necrosis may occur. SYSTEMIC EFFECTS: Nausea, vomiting and diarrhea are common.
    2) SEVERE TOXICITY: LOCAL TISSUE INJURY: Tissue necrosis in severe envenomations may require surgical debridement and amputations. COAGULOPATHY: Thrombocytopenia, prolonged PT/INR and PTT, decreased fibrinogen levels, increased fibrin degradation products and inhibition of platelet aggregation are produced by the venom of many vipers. Direct damage to vascular endothelium in some species can also result in hemorrhage. Rarely, bites have led to thrombotic events and disseminated intravascular coagulopathy. Bleeding complications can include bleeding gums, hemoptysis, hematemesis, rectal bleeding, melena, hematuria, vaginal bleeding, and bleeding from old wound sites or venipuncture sites, and rarely intracranial hemorrhage. Rhadomyolysis can occur following severe envenomations. Multiple cases of compartment syndrome have been described after envenomation by B. arietans. Envenomations can produce hypotension which is mainly associated with hypovolemia but can occur from direct cardiotoxicity (B. arietans). Neurotoxicity has been reported infrequently. Both ischemic and hemorrhagic strokes have been reported with Cerastes cerastes.
    0.2.13) HEMATOLOGIC
    A) WITH POISONING/EXPOSURE
    1) Coagulopathy with thrombocytopenia, prolonged PT/INR and PTT, increased fibrin degradation products and decreased fibrinogen are common manifestations of moderate to severe envenomation. Localized and spontaneous systemic bleeding have been reported after viper bites.
    0.2.20) REPRODUCTIVE
    A) Limited data are available regarding the effects of venom and antivenom on a human fetus. The risk of snake antivenom therapy in pregnancy is not available. Exposure may result in teratogenesis; mice and chicken embryos showed evidence of teratogenic effects after exposure to snake venom.
    B) In a series of 10 pregnant women, who were bitten by E. ocellatus in their 20th to 36th week of gestation, all patients survived with antivenom therapy and supportive care; fetal loss was reported in only one of the 10 patients.
    0.2.22) OTHER
    A) WITH POISONING/EXPOSURE
    1) Fatalities have been reported following envenomation by many of the species within this region, but cases are generally infrequent. Children appear to have higher death rates (all species) as compared to adults.

Laboratory Monitoring

    A) Monitor vital signs and mental status.
    B) Monitor for progression of edema, pain and lymphadenopathy.
    C) Mark leading edge of soft tissue swelling and measure circumference at the area of the bite, reassess for progression every 15 to 30 minutes.
    D) The following tests should be obtained upon admission and repeated every 6 hours to assess worsening envenomation and/or efficacy of antivenom:
    1) Obtain complete blood count with differential. Monitor coagulation studies including INR, PTT, fibrinogen, fibrin degradation products, and whole blood clotting time over 20 minutes if other tests are not available.
    2) Obtain serum electrolytes, renal function tests and urinalysis and repeated as needed.
    3) Culture wound if evidence of secondary infection is present.
    E) Caution should be used in all venipuncture studies due to the risk of bleeding and/or oozing that may occur at the site. Arterial punctures should be avoided when possible, particularly in incompressible sites.

Treatment Overview

    0.4.7) BITES/STINGS
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) Mild to moderate envenomations can be observed for at least 24 hours in a health care facility. Antivenom may be warranted if clinical or laboratory markers worsen. Mild hypotension can be managed by intravenous fluid administration. Antiemetics and analgesia may be administered for mild systemic symptoms.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Systemic effects or severe local tissue injury should be treated with antivenom. Hypotension or shock that is unresponsive to fluids may require vasopressor agents (eg, dopamine, norepinephrine, or epinephrine) if antivenom is not available. Coagulation abnormalities and hemorrhage can be treated with clotting factors and platelets (eg, fresh frozen plasma and cryoprecipitate with platelet concentrates) if antivenom is not available. Patients who develop rhabdomyolysis need aggressive hydration. Acute renal failure will need adequate hydration and may need dialysis. For suspected compartment syndrome, surgical consult may be indicated after a viper envenomation in the presence of severe swelling to rule out compartment syndrome. Early antivenom administration remains an effective measure to prevent or minimize irreversible muscle damage. Surgical procedures should be based on documented compartment pressure that are consistent with compartment syndrome and do not improve with antivenom.
    C) DECONTAMINATION
    1) Remove constricting clothing, and jewelry from the bitten limb. Immobilize the limb at heart level and transport the patient to a medical facility as soon as possible. Pressure immobilization is not recommended in viper bites as it can increase local tissue injury. Do NOT use a tourniquet or use cautery, incision, suction, instillation of chemical compounds, application of ice, or electric shock.
    D) AIRWAY MANAGEMENT
    1) Significant facial, oropharyngeal or laryngeal swelling from local toxicity or allergic reactions can quickly compromise the airway. Perform early intubation if any stridor or signs of airway obstruction. Cricothyrotomy may be necessary in severe cases
    E) BITE/WOUND
    1) Clinical Assessment: Early and thorough clinical assessment for progression of local injury and development of systemic symptoms are of the utmost importance. Wound Management: Wounds should be gently cleaned and monitored closely for signs of progression. Blisters and bullae should be left intact. Update tetanus immunization, if necessary.
    F) ANTIVENOM
    1) Antivenom is indicated after a viper snake bite if the following effects are present: severe local envenomation (eg, local swelling involving more than half the limb or lymph node involvement, swelling of digits), coagulation abnormalities (eg, spontaneous bleeding, laboratory evidence of coagulopathy), generalized rhabdomyolysis, or neurotoxicity. Administration of antivenom can reverse systemic envenomation effects even after several days, but cannot reverse established tissue necrosis and may be less effective on effects of local envenomation unless given within several hours after the bite. Approximately 22 antivenom formulations from 10 countries are available with claimed efficacy to various species of Viperidae in this region (Note: See detailed treatment section for specific antivenoms). If the snake species is positively identified, administer a species-specific antivenom when available. Regional polyspecific antivenoms are appropriate when the snakes species cannot be reliably identified or a species-specific antivenom is not available. A regional poison center can provide information on and help locate antivenoms for exotic species. Antivenoms can produce acute allergic reactions. Begin administration slowly with careful monitoring for allergic reactions and resuscitation equipment at the bedside. Gradually increase the rate of administration as tolerated. Consultation with a medical toxicologist or toxinologist is strongly recommended. The dosage of the antivenom should be guided by symptoms, signs, and laboratory findings. To prevent local tissue necrosis, antivenom should be given as soon as possible.
    G) ENHANCED ELIMINATION
    1) There is no role for enhanced elimination in the management of African viper bites.
    H) PATIENT DISPOSITION
    1) HOME CRITERIA: There should be NO home treatment for bites from proven or suspected venomous snakes. The goal of prehospital care is rapid transport to a healthcare facility.
    2) OBSERVATION CRITERIA: Any patient suspected of having been bitten by an African viper should be referred to healthcare facility and closely observed for a period of 24 hours.
    3) ADMISSION CRITERIA: Any patient who has been bitten by a proven or suspected venomous viper should be admitted to a hospital for a 24 hour observation period. Any patient with coagulopathy, hypotension, neurotoxicity, or airway compromise or who requires antivenom administration should be admitted to an intensive care setting.
    4) CONSULT CRITERIA: Consult a local herpetologist for proper identification of the snake if it is available. Consultation with a medical toxicologist or a toxinologist is strongly recommended with administration of antivenom. A local poison center can provide information on the appropriate antivenom and how to obtain it for bites by exotic species.
    I) PITFALLS
    1) Failure to monitor carefully for progression of local tissue injury or development/worsening of systemic effects; antivenom is most effective if given early.
    J) TOXICOKINETICS
    1) Onset of symptoms is usually immediate with subsequent severe pain, erythema and swelling after a bite. Swelling usually begins to develop within 15 minutes of a viper envenomation. Venom can be rapidly absorbed and evidence of bruising, blistering and necrosis can be present within 24 hours. In general, the later the onset of systemic symptoms, the better the prognosis (ie, less venom absorbed).
    K) DIFFERENTIAL DIAGNOSIS
    1) Early signs and symptoms may mimic envenomation from other creatures (eg, scorpions, hymenoptera and spiders, other vipers). Local tissue injury can resemble or be concurrently present with cellulitis or other soft tissue infections (eg, necrotizing fascitis). Systemic findings warrant evaluation for trauma, sepsis, metabolic derangement and/or other toxic substances.

Range Of Toxicity

    A) TOXICITY: An estimated 20% to 50% of snake bites result in no actual envenomation - "dry bite". In general, fatalities are more common in children than adults. Fatalities have been reported among the genus Bitis with most reported among B. arietans. Infrequent to rare reports of fatalities have also occurred following the envenomation by the genus Echis (E. coloratus, E. ocellatus, and E. pyramidum considered the most common cause of fatal snakebite in the Sudan) and the genus Vipera (V. latasti, V. macrovipera lebetina, and V. palaestinae).

Summary Of Exposure

    A) USES: This management is limited to the vipers of Africa and the surrounding region of most medical importance. Some geographic overlap may occur in this management with venomous snakes of the Middle East. Please refer to the SNAKES, MIDDLE-EASTERN management as appropriate. There are over 45 species that inhabit this region. In particular, the saw-scaled or carpet vipers (genus Echis), the puff adder (Bitis arietans), and the Gaboon viper (B. gabnonica) are of significant medical importance.
    B) TOXICOLOGY: Snake venom varies in composition and quantity dependent on the species and size of the snake and the mechanical efficiency in which the bite occurred. Clinically important components of venom include proteolytic/procoagulant enzymes, cytolytic/necrotic toxins, hemolytic/myolytic phospholipase A2, neurotoxins, vasodilators and hemorrhagins.
    C) EPIDEMIOLOGY: True epidemiologic data on African snakebites are difficult to ascertain. The World Health Organization estimates 100,000 envenomations and 5,000 deaths from African snakes (including Viperidae and Elapidae) annually in 2010. Because of the inaccuracies of reporting systems, the estimate of the annual incidence is as high as 1,000,000 bites with 500,000 envenomations and 20,000 deaths.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE TOXICITY: LOCAL TISSUE INJURY: An estimated 20% to 50% of snake bites do not result in envenomation - "dry bite". Localized pain and swelling occur after envenomation by most species of vipers; localized bleeding is also relatively common and tissue necrosis may occur. SYSTEMIC EFFECTS: Nausea, vomiting and diarrhea are common.
    2) SEVERE TOXICITY: LOCAL TISSUE INJURY: Tissue necrosis in severe envenomations may require surgical debridement and amputations. COAGULOPATHY: Thrombocytopenia, prolonged PT/INR and PTT, decreased fibrinogen levels, increased fibrin degradation products and inhibition of platelet aggregation are produced by the venom of many vipers. Direct damage to vascular endothelium in some species can also result in hemorrhage. Rarely, bites have led to thrombotic events and disseminated intravascular coagulopathy. Bleeding complications can include bleeding gums, hemoptysis, hematemesis, rectal bleeding, melena, hematuria, vaginal bleeding, and bleeding from old wound sites or venipuncture sites, and rarely intracranial hemorrhage. Rhadomyolysis can occur following severe envenomations. Multiple cases of compartment syndrome have been described after envenomation by B. arietans. Envenomations can produce hypotension which is mainly associated with hypovolemia but can occur from direct cardiotoxicity (B. arietans). Neurotoxicity has been reported infrequently. Both ischemic and hemorrhagic strokes have been reported with Cerastes cerastes.

Vital Signs

    3.3.3) TEMPERATURE
    A) WITH POISONING/EXPOSURE
    1) Fever can develop in some cases of viper envenomation.
    a) In a small case study of 31 victims of viper bite, fever was reported in patients with E. carinatus or a B. arietans bite. Neutrophil leukocytosis was also present in some patients with fever (Pugh & Theakston, 1987).

Heent

    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) PTOSIS may occur following viper envenomations.
    a) CASE REPORT: Bilateral ptosis developed in a young adult following an Echis pyramidum (carpet viper) bite. Symptoms developed within the first 3 days and resolved within one week following antivenom administration and supportive care (Gillissen et al, 1994).

Cardiovascular

    3.5.2) CLINICAL EFFECTS
    A) HYPOTENSIVE EPISODE
    1) WITH POISONING/EXPOSURE
    a) SUMMARY: The venom of vipers in this region can produce hypotension. In victims of viper envenomation, hypotension is mainly associated with hypovolemia (Warrell, 1995; Blaylock, 2003).
    b) PATHOPHYSIOLOGY: Viper venom can produce a decline in blood pressure by increasing vascular permeability leading to hypovolemia. Some species (i.e., B. gabonica, B. arietans) can have a direct effect on the heart and other species (i.e., B. arietans) can produce splanchnic vasodilatation, and autopharmacological release of vasodilators, such as bradykinin release in some species (e.g., V. palaestinae) (Warrell, 1995).
    c) The almost immediate clinical improvement in blood pressure by the administration of antivenom following some viper envenomations (e.g., B. arietans) suggests a direct myocardial effect (Warrell, 1995).
    d) CASE REPORT: A 43-year-old man developed episodic premature ventricular contractions and hypotension (80/50 mmHg) after being bitten on his left thumb by Bitis gabonica (gaboon viper). The patient also experienced ecchymosis and edema at the bite site, paresthesias extending to the mid wrist, and chest tightness. Following intravenous administration of 10 vials of antivenom, given over a six-hour period, and administration of diphenhydramine and hydrocortisone, the patient recovered and was discharged 3 days post-envenomation (Marsh et al, 2007).
    B) SHOCK
    1) WITH POISONING/EXPOSURE
    a) Shock can be a clinical feature of the genus Bitis (B. arietans {puff adder} and B. gabonica {Gaboon viper}) envenomations. In victims of viper envenomation, shock was mainly associated with hypovolemia (Warrell, 1995).
    b) INCIDENCE: B. gabonica bites are more likely to produce severe cardiovascular effects than are B. arietans bites (Warrell, 1995).
    1) Envenomations by the genus Echis (saw-scaled or carpet vipers) can produce shock, but it has been reported infrequently. Likewise, the genus Vipera (typical old world vipers) can cause severe systemic effects which may include shock.
    c) CASE REPORT: A 40-year-old man experienced hypotensive shock approximately 2.5 hours following envenomation by M. lebetina lebetina (blunt-nosed viper). Antivenom was not available; the patient recovered with supportive care (Gocmen et al, 2006).
    C) CONDUCTION DISORDER OF THE HEART
    1) WITH POISONING/EXPOSURE
    a) The following dysrhythmias have been associated with B. arietans (puff adder) and B. gabonica (Gaboon viper) envenomations: bradycardia, atrial tachycardia with ectopic beats, and ECG changes associated with myocardial damage (Warrell, 1995).
    b) The almost immediate clinical improvement in bradycardia by the administration of antivenom following some viper envenomations (e.g., B. arietans) suggests a direct myocardial effect (Warrell, 1995).
    c) CASE REPORT: A 43-year-old man developed episodic premature ventricular contractions and hypotension (80/50 mmHg) after being bitten on his left thumb by Bitis gabonica (gaboon viper). The patient also experienced ecchymosis and edema at the bite site, paresthesias extending to the mid wrist, and chest tightness. Following intravenous administration of 10 vials of antivenom, given over a six-hour period, and administration of diphenhydramine and hydrocortisone, the patient recovered and was discharged 3 days post-envenomation (Marsh et al, 2007).
    D) HYPERTENSIVE DISORDER
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Hypertension (180/100 mmHg) was reported in a 57-year-old man within 24 hours following envenomation from Proatheris supercilius (Lowland Swamp viper) (Valenta et al, 2008).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) DYSPNEA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 40-year-old man experienced uncontrolled movements of his arms and legs, faintness, tremors, dyspnea, tachycardia, and sweating approximately 2.5 hours after being bitten on the finger of his right hand by a blunt-nosed viper (M. lebetina lebetina). The symptoms spontaneously disappeared 20 minutes later (Gocmen et al, 2006).
    B) PULMONARY EMBOLISM
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 16-year-old adolescent experienced dyspnea and severe pleuritic chest pain following a 1-week hospitalization for a snake bite from an Egyptian sand viper (Cerastes cerastes). Chest radiograph was normal; however, a pulmonary angiogram confirmed the presence of an embolus in the left pulmonary artery. Symptoms persisted despite heparin administration, and an intermittent fever (38.9 degrees C) developed. Further complications ensued, including pleural effusion and a clostridial infection. With supportive therapy, the patient recovered and was discharged (Halkin et al, 1997).

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) CENTRAL NERVOUS SYSTEM FINDING
    1) WITH POISONING/EXPOSURE
    a) Neurotoxicity is not a typical feature of viper envenomation.
    b) The following neurotoxic effects have been reported for specific African vipers (Warrell, 1995):
    1) B. gabonica (gaboon viper): Some reports of dizziness, blurred vision and difficulty with visual accommodation have occurred, but ptosis (a common clinical feature of neurotoxicity following elapid envenomation) has not been reported.
    2) B. atropos (berg adder): Neurotoxic effects may develop and last several hours or up to a week.
    3) E. pyramidum (Egyptian carpet viper): Neurotoxicity has been reported.
    4) Neurotoxin venom has been found in the venoms of the following: B. caudalis (horned adder) and the B. atropos (berg adder); V. palaestinae (Palestine viper) has a neurotoxic polypeptide that can act directly on the medulla.
    5) Coma was reported in 2 patients (a 9-year-old boy and a 26-year-old man) who presented to the hospital 69 and 95 hours, respectively, after being bitten by Echis ocellatus. Despite administration of antivenom, both patients died within 2 days after presentation (Einterz & Bates, 2003).
    c) CASE REPORT: Bilateral ptosis developed in a young adult following an Echis pyramidum (carpet viper) bite. Symptoms developed within the first 3 days and resolved within one week following antivenom administration and supportive care (Gillissen et al, 1994).
    d) CASE REPORT: A research scientist developed facial and tongue numbness after using her bare hands to remove residual petroleum jelly from a dish that had previously contained dendrotoxin and then rubbing her eye. Dendrotoxin is derived from the venom of the green mamba (Dendroaspis angusticeps). Weakness on superior gaze and tongue fasciculations were present. Signs and symptoms resolved within 12 hours (Munday et al, 2003).
    e) CASE REPORT: A 40-year-old man experienced uncontrolled movements of his arms and legs, faintness, tremors, dyspnea, tachycardia, and sweating approximately 2.5 hours after being bitten on the finger of his right hand by a blunt-nosed viper (M. lebetina lebetina). The symptoms spontaneously disappeared 20 minutes later (Gocmen et al, 2006).
    B) CEREBRAL HEMORRHAGE
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Thrombosis has been reported following viper exposure infrequently and has produced hemorrhagic and ischemic stroke (Rebahi et al, 2014; Aissaoui et al, 2013; Pugh & Theakston, 1987).
    b) CASE REPORT
    1) CERASTES CERASTES (Desert-horned or Egyptian sand viper): Three patients developed acute ischemic cerebrovascular events after severe envenomation by C. cerastes vipers (Rebahi et al, 2014).
    a) A 32-year-old woman was bitten by a horned viper on her hand and the following day developed tonic-clonic seizures. Upon admission she had a Glasgow Coma Scale score of 12 and spontaneous bleeding of the gums. Her CNS function further declined (GCS 8) and she was electively intubated and ventilated. Two days after envenomation, a CT of the brain showed an extensive infarction of the brain including frontal, temporal, and parietal lobes with cerebral edema. She also had laboratory evidence of disseminated intravascular coagulation. Despite supportive care, her CNS function did not improve and she died (Rebahi et al, 2014).
    b) A 5-year-old girl was hospitalized with confusion, polypnea, and compartment syndrome in her lower limb 4 days after being bitten by a C. cerastes viper. She required immediate intubation and ventilation. Coagulation studies were abnormal. A CT scan of the brain showed an extensive frontal-parieto-occipital ischemic stroke. Although she received supportive care, her neurologic function continued to decline and she died on day 7 (Rebahi et al, 2014).
    c) A 51-year-old man was bitten by a C. cerastes viper and early on developed compartment syndrome of his right limb, hemodynamic shock, rhabdomyolysis and hyperkalemia. He also had evidence of DIC. A fasciotomy was performed and 48 hours later his neurologic function declined and his Glasgow Coma Scale score dropped to 10. A CT scan of brain showed acute bilateral cerebral infarctions in internal capsules. He was intubated and ventilated and successfully extubated on day 7. He gradually recovered and his neurologic function was normal at 3 months (Rebahi et al, 2014).
    2) ECHIS CARINATUS (carpet viper): A 65-year-old woman who arrived several hours after receiving a bite by an E. carinatus (carpet viper) was drowsy on admission and later died from a subarachnoid hemorrhage (Pugh & Theakston, 1987).
    C) PARESTHESIA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Paresthesias, extending to the mid-wrist, occurred in a 43-year-old man who was bitten on his left thumb by B. gabonica (gaboon viper) (Marsh et al, 2007).

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) NAUSEA, VOMITING AND DIARRHEA
    1) WITH POISONING/EXPOSURE
    a) Generalized symptoms of nausea, vomiting, abdominal pain or diarrhea may be present after a viper envenomation (Valenta et al, 2008; Marsh et al, 2007; Mebs et al, 1998; Warrell, 1995; Pugh & Theakston, 1987).

Genitourinary

    3.10.2) CLINICAL EFFECTS
    A) ACUTE RENAL FAILURE SYNDROME
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Acute renal failure has been reported after bites by vipers (e.g., Echis pyramidum {carpet viper})(Gillissen et al, 1994), and is characteristic of severe envenomation (Warrell, 1995).
    b) CASE REPORTS
    1) E. pyramidum (carpet viper): Renal impairment (serum creatinine (mg/dL) 1.1 on admission increasing to 4.8 on hospital day 3 and blood urea (mg/dL) of 7 increasing to 70 on hospital day 4) was reported in a 22-year-old man after envenomation by a carpet viper. Laboratory studies improved within 7 days of envenomation and dialysis was not necessary (Gillissen et al, 1994).
    2) Atheris chlorechis (Western bush viper): Thrombocytopenia, severe coagulopathy with profound blood loss, and acute renal failure occurred in a 26-year-old man who was bitten on his left index finger by a Western bush viper (A. chlorechis). Laboratory analysis revealed a urea level and a serum creatinine level that peaked at 17.2 mmol/L (normal 3.3 to 6.7 mmol/L) and 314 mcmol/L (normal 62 to 106 mcmol/L), respectively, at approximately 17.5 hours post-envenomation. Following antivenom administration and supportive treatment, including hemodialysis, the patient gradually recovered (Top et al, 2006).
    3) Proatheris superciliaris: A 57-year-old man developed oliguria (10 to 15 mL/hour) following envenomation by a Lowland swamp viper (P. superciliaris). Laboratory data revealed serum creatinine and BUN levels that peaked at 617 mcmol/L and 25.3 mmol/L, respectively, 8 days post-envenomation. Following continuous venovenous hemodiafiltration (CVVHDF) and intermittent hemodialysis, the patient gradually recovered (Valenta et al, 2008). Another patient developed renal insufficiency with oliguria, elevated serum creatinine and BUN levels, and hemoglobinuria following envenomation by P. superciliaris. The patient's renal function gradually improved following daily plasmapheresis treatments over a 7-day period (Keyler, 2008).
    B) BLOOD IN URINE
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Hematuria may develop in victims of viper envenomations with severe coagulopathy or thrombocytopenia (Pugh & Theakston, 1987).
    b) CASE REPORTS
    1) C. maculatus (Western rhombic night adder): Transient hematuria has been reported in victims of C. maculatus bites; no intervention was required and hematuria resolved spontaneously (Pugh & Theakston, 1987).

Hematologic

    3.13.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Coagulopathy with thrombocytopenia, prolonged PT/INR and PTT, increased fibrin degradation products and decreased fibrinogen are common manifestations of moderate to severe envenomation. Localized and spontaneous systemic bleeding have been reported after viper bites.
    3.13.2) CLINICAL EFFECTS
    A) BLOOD COAGULATION PATHWAY FINDING
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Coagulopathy with thrombocytopenia, prolonged PT/INR and PTT, increased fibrin degradation products and decreased fibrinogen are common manifestations of moderate to severe envenomation. Coagulation disorders that are produced by vipers are usually reversed when antivenom is administered promptly (Marsh et al, 2007; Hantson et al, 2003; Pugh & Theakston, 1987; Warrell, 1995).
    2) CASE REPORT: A 57-year-old man developed coagulopathy with a prolonged PT/INR and a decreased fibrinogen concentration, thrombocytopenia, and hemolysis after being bitten by Proatheris superciliaris. There is no specific antivenom available; the patient's laboratory values normalized following administration of fresh frozen plasma, platelets and packed red cells (Valenta et al, 2008).
    3) CASE REPORT: A 34-year-old man was bitten by a green bush viper (Atheris squamiger) and within 90 minutes developed coagulopathy with a prolonged PT (greater than 100 sec; normal 15 to 20 sec) and PTT (greater than 180 sec; normal 26 to 40 sec) and a decreased plasma fibrinogen concentration (less than 0.5 g/L; normal 1.5 to 3 g/L), thrombocytopenia, and leukocytosis. No specific antivenom was available; the patient gradually recovered following supportive therapy (Mebs et al, 1998).
    B) THROMBOCYTOPENIC DISORDER
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Thrombocytopenia has developed after viper envenomations (Keyler, 2008; Valenta et al, 2008; Top et al, 2006; Mebs et al, 1998; Pugh & Theakston, 1987).
    2) CASE SERIES: In a review of 13 victims of E. carinatus envenomation, only 2 developed mild symptoms of thrombocytopenia (Pugh & Theakston, 1987).
    C) ECCHYMOSIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORTS
    1) Twenty hours after a snake bite on the finger (antivenom not available), ecchymosis extended into the axilla and chest wall of a man envenomated by a B. arietans (puff adder). No further progression of ecchymosis occurred after receiving antivenom (Bey et al, 1997).
    2) Ecchymosis was reported in two patients following envenomation by a B. gabonica (gaboon viper) (Marsh et al, 2007). In one of the patients, a 43-year-old man, the ecchymosis was localized, occurring at the base of the left thumb. In the other patient, a 33-year-old woman who was found dead approximately 3 days following envenomation, the ecchymosis was more generalized, appearing at the head, trunk, and extremities, indicating extensive internal bleeding.
    3) Ecchymoses of the upper arm, deltoid, and pectoral areas were reported in a 33-year-old man who was bitten on his left hand by M. lebetina (levantine viper) (Sharma et al, 2008).
    D) HEMORRHAGE
    1) WITH POISONING/EXPOSURE
    a) SUMMARY: Hematological effects can result in bleeding from multiple sites (e.g., bleeding gums, hemoptysis, hematemesis, rectal bleeding, melena, hematuria, vaginal bleeding, and bleeding from old wound sites or venipuncture sites) (Marsh et al, 2007; Top et al, 2006; Einterz & Bates, 2003; Gillissen et al, 1994). The Echis species can produce spontaneous bleeding and incoagulable blood (Pugh & Theakston, 1987) (Mebs et al, 1988).
    1) INCIDENCE: In a small case series of 26 viper bites, all victims of an E. carinatus bite developed spontaneous bleeding; the mean onset was 8 hours after the bite with a range of 0.5 to 25 hours. The most frequent site of bleeding was the gingival sulcus (Pugh & Theakston, 1987).
    b) CASE REPORTS
    1) ECHIS
    a) E. pyramidum (carpet viper) - Moderate bleeding from the gums, gastrointestinal tract, urinary tract, trachea and injection sites was reported in a 22-year-old man 24 hours after receiving a bite from a carpet viper. The bleeding persisted for 4 days. Despite antivenom administration the patient required two blood transfusions to correct the anemia (Hgb 14.3 g/dL on admission to 6.9 g/dL on the 8th day after the bite). Symptoms stabilized and the patient was discharged on day 17 (Gillissen et al, 1994).
    b) In a case series of 13 victims of E. carinatus bites that responded to antivenom therapy, all patients had incoagulable blood at the time of admission with normal clotting occurring 12 to 54 hours after antivenom administration; spontaneous bleeding stopped between 2 and 20 hours after antivenom therapy.
    1) In patients with delayed or failed response to antivenom administration, spontaneous bleeding continued in 6 of 7 patients up to 36 hours after admission (Pugh & Theakston, 1987).
    c) In a series of 59 patients who were bitten by E. ocellatus, 5 patients who presented 2 hours or less after envenomation were not bleeding at the time of presentation, 14 of 22 patients (64%) presenting 2 to 5 hours after envenomation were bleeding, and 25 of 32 patients (68%) presenting 6 hours or more after envenomation were bleeding at the time of presentation (Einterz & Bates, 2003). All 8 patients who died presented with life threatening complications related to bleeding, 5 with neurologic findings suggesting intracranial or meningeal bleeding, 3 with intra-abdominal or gastrointestinal bleeding, and 1 with acute airway obstruction from tongue and sublingual bleeding.
    2) Bitis gabonica (gaboon viper): A 55-year-old man with suspected gaboon viper envenomation developed hypotension, severe coagulopathy (fibrinogen not measurable, D-dimer 8,000, INR >7), anemia (hematocrit 16%), and multiple hematomas, bleeding at puncture sites and hemoperitoneum. Coagulopathy did not correct with administration of 8 units fresh frozen plasma and 2 grams of fibrinogen, but rapidly corrected after 2 vials of trivalent antivenom (Hantson et al, 2003).
    3) Atheris chlorechis (Western bush viper): A 26-year-old man developed severe coagulopathy (PT greater than 120 sec; APTT greater than 200 sec) and blood loss approximately 7 hours after being bitten on his left index finger by a Western bush viper (Atheris chlorechis) and following performance of two fasciotomies. The patient's lab values normalized following treatment with fresh frozen plasma; however, his bleeding progressively worsened, with a blood loss of approximately 5 liters during the first six hours of his stay in ICU. His hemoglobin level and platelet count declined to a low of 3.7 mmol/L (normal 8.7 to 10.6 mmol/L) and 19 x 10(9)/L (normal 150 to 350 x 10(9)/L), respectively. Following administration of the antivenom, given approximately 12 hours post-envenomation, the patient's blood loss slowly diminished over the next several days (Top et al, 2006).
    E) DISSEMINATED INTRAVASCULAR COAGULATION
    1) WITH POISONING/EXPOSURE
    a) CERASTES VIPERA (Sahara sand viper): A 3-year-old boy was bitten on the foot by a C. vipera (the snake was killed and identified at the hospital) and admitted 3 hours after exposure in generally good condition with a slightly elevated heart rate (122 beats/min). His foot was markedly swollen with blood oozing from the bite site. However, his foot continued to swell and his initial coagulation studies were abnormal. By the end of day 1, hemoglobin was 9.1, PT and PTT were immeasurably prolonged and reduced platelets were present along with oozing observed from the venipuncture site along with hematemesis and rectal bleeding consistent with disseminated intravascular coagulation (DIC). Treatment included fresh frozen plasma (FFP), cryoprecipitate, vitamin K, packed cells and IV platelets in repeated doses for 5 days. Despite repeated administration of blood products, coagulation studies remained abnormal requiring a total exchange transfusion (1200 mL of fresh blood) 3 days after envenomation. The child gradually improved and coagulation studies returned to normal 6 days after the bite. Polyvalent antivenom (a specific antivenom was not available) did not arrive until after the child had clinically improved and was not administered (Lifshitz et al, 2000).
    b) CERASTES CERASTES: A 32-year-old woman was bitten by a horned viper on her hand and the following day developed tonic-clonic seizures. Upon admission she had a Glasgow Coma Scale score of 12 and spontaneous bleeding of the gums. Her CNS function further declined (GCS 8) and she was electively intubated and ventilated. Two days after envenomation, a CT of the brain showed an extensive infarction of the brain including frontal, temporal, and parietal lobes with cerebral edema. She also had laboratory evidence of disseminated intravascular coagulation. Despite supportive care, her CNS function did not improve and she died (Rebahi et al, 2014).
    c) CERASTES CERASTES: A 51-year-old man was bitten by a C. cerastes viper and early on developed compartment syndrome of his right limb, hemodynamic shock, rhabdomyolysis and hyperkalemia. He also had evidence of DIC. A fasciotomy was performed and 48 hours later his neurologic function declined and his Glasgow Coma Scale score dropped to 10. A CT scan of brain showed acute bilateral cerebral infarctions in internal capsules. He was intubated and ventilated and successfully extubated on day 7. He gradually recovered and his neurologic function was normal at 3 months (Rebahi et al, 2014).
    F) LEUKOCYTOSIS
    1) WITH POISONING/EXPOSURE
    a) Leukocytosis may occur after viper envenomation. Bites by the E. carinatus (carpet viper) have resulted in neutrophil leukocytosis (Pugh & Theakston, 1987).
    b) INCIDENCE: In a review of 13 patients with E. carinatus envenomation, 5 developed neutrophil leukocytosis (greater than 7600 mm(-3)) (Pugh & Theakston, 1987).
    c) CASE REPORT: Leukocytosis was reported in a 34-year-old man approximately 90 minutes following envenomation by a green bush viper (Atheris squamiger). The leukocyte count gradually decreased after reaching a peak of 22,100/ mcL (Mebs et al, 1998).
    G) THROMBOTIC MICROANGIOPATHY
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: 27-year-old man was bitten by Proatheris superciliaris and subsequently developed microangiopathic hemolysis, thrombocytopenia, schistocytosis, an elevated LDH, and worsening renal function, all of which is consistent with a diagnosis of thrombotic microangiopathy. The patient gradually improved with daily plasmapheresis treatments over a 7-day period (Keyler, 2008).

Dermatologic

    3.14.2) CLINICAL EFFECTS
    A) EDEMA
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Swelling and erythema are likely to occur following any viper envenomation (Keyler, 2008; Valenta et al, 2008; Top et al, 2006; Bey et al, 1997). Swelling may be localized or progress to involve the entire affected limb and include the regional lymphatic system (Marsh et al, 2007; Meier & White, 1995a; Gillissen et al, 1994; Bey et al, 1997).
    b) REGIONAL EFFECTS
    1) B. arietans (puff adder): A 35-year-old man was bitten on his finger by a juvenile puff adder and developed immediate pain followed by edema and swelling which started minutes later. Due to a delay in antivenom administration, edema and ecchymosis extended into the axilla and chest wall over the next 20 hours; signs and symptoms responded to antivenom administration (Bey et al, 1997).
    2) B. arietans (puff adder): A 50-year-old woman was admitted 16.5 hours after receiving a bite on the leg by a B. arietans and developed swelling in the entire leg with blistering and bruising around the bite site. Antivenom was given; blistering and swelling improved by the fourth day (Pugh & Theakston, 1987).
    3) Macrovipera lebetina lebetina (blunt-nosed viper): A 40-year-old man was bitten on the finger of his right hand by a blunt-nosed viper (M. lebetina lebetina) and immediately experienced swelling of the finger. Within 3 hours post-envenomation, the swelling extended to the middle of his right arm. Antivenom was not available; the patient recovered with supportive care (Gocmen et al, 2006). Another patient, a 33-year-old man, who was also bitten by M. lebetina on his little finger of his left hand, developed swelling at the bite site that continued to progress from his left hand and arm to the left pectoral region over a period of 48 hours. Fasciotomy of the hand was performed in order to prevent ischemic damage (Sharma et al, 2008).
    c) LOCALIZED EFFECTS
    1) Bitis schneideri (Namaqua dwarf adder): An adult was bitten on the finger by a Namaqua dwarf adder and developed localized swelling of the finger and hand with only tenderness occurring in the axillary lymph node region. Swelling and pain remained and gradually lessened over days 5 through 14 with complete healing at 2 weeks. Supportive care included elevation, analgesics, and antibiotic therapy; antivenom was not used (Hurrell, 1981).
    2) C. maculatus (Western rhombic night adder) - Local swelling occurred within 15 minutes of envenomation in 3 patients exposed. The authors noted that symptoms were limited to local pain and swelling only; symptoms resolved spontaneously without antivenom (Pugh & Theakston, 1987).
    3) A 27-year-old man was bitten on his left index finger by Proatheris superciliaris and developed immediate swelling that extended to the dorsum of his right hand and up to the crease in his wrist (Keyler, 2008).
    B) PAIN
    1) WITH POISONING/EXPOSURE
    a) SUMMARY: Envenomation by vipers and adders usually produce immediate intense local pain (Hurrell, 1981; Pugh & Theakston, 1987; Bey et al, 1997; Top et al, 2006; Marsh et al, 2007; Keyler, 2008).
    C) BLISTERING ERUPTION
    1) WITH POISONING/EXPOSURE
    a) Local blistering may occur within 24 hours of a viper envenomation.
    1) INCIDENCE: In a series of 26 patients with snakebites by E. carinatus, B. arietans, or C. maculatus, 3 patients (12%) developed local blistering (Pugh & Theakston, 1987).
    D) SKIN NECROSIS
    1) WITH POISONING/EXPOSURE
    a) Tissue necrosis can occur after viper envenomation and may require surgical debridement (Pugh & Theakston, 1987; Bey et al, 1997) or amputation (Sharma et al, 2008). Necrosis appears to be more prevalent after bites sustained on fingers or toes (Bey et al, 1997).
    b) CASE REPORT: A 26-year-old man who was bitten on his left index finger by a Western bush viper (Atheris chlorechis) developed a small necrotic area at the bite site (Top et al, 2006).
    c) CASE REPORT: A 27-year-old man was bitten on his left index finger by Proatheris superciliaris and, 36 hours later, developed necrosis from the base of the fingernail to the proximal interphalangeal joint. The necrosis remained localized, but required debridement and irrigation with saline and antibiotics (Keyler, 2008).
    E) SWEATING
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 40-year-old man experienced uncontrolled movements of his arms and legs, faintness, tremors, dyspnea, tachycardia, and sweating approximately 2.5 hours after being bitten on the finger of his right hand by a blunt-nosed viper (M. lebetina lebetina). The symptoms spontaneously disappeared 20 minutes later (Gocmen et al, 2006).

Musculoskeletal

    3.15.2) CLINICAL EFFECTS
    A) COMPARTMENT SYNDROME
    1) WITH POISONING/EXPOSURE
    a) Compartment syndrome is more likely to occur, especially in the anterior tibial fascial compartment, following bites in which venom is injected into a tight fascial compartment (Warrell, 1995). Compartment syndrome has been reported in 2 patients bitten by C. cerastes (Desert horned or Egyptian sand vipers) (Rebahi et al, 2014).
    b) CASE REPORT: A 16-year-old girl living in Kokstad was bitten by a B. arietans (puff adder) in both upper extremities (left finger and right hand) while sleeping and developed loss of sensory function, loss of opposition of the thumb and almost no movement at the joints. Polyvalent antivenom was given approximately 2 hours (upon hospital arrival) after envenomation.
    1) The clinical impression of raised intracompartmental pressure (measuring of intracompartmental pressures was not possible at this hospital) was made. Bilateral carpal tunnel release was performed with operative findings of clotted blood found under the palmar fascia with edema at the carpel tunnel and cyanotic appearance of the nerve; 35 days after surgery the patient had full motor and sensory function of both hands (Schweitzer & Lewis, 1981).
    c) CASE REPORT: A 15-year-old boy sustained a suspected puff adder (Bitis arietans) bite above the right ankle and presented 15 hours after envenomation with severe swelling of the leg into the chest wall, hypotension, anemia, and coagulopathy. The leg was tense below the knee with no pedal pulses. He was resuscitated with fluid and blood products and then developed severe hypotension after an attempt to administer antivenom. Antivenom was stopped and he received a four-compartment below-knee fasciotomy and an anterior thigh fasciotomy. Blood flow to the leg was not restored until the inguinal ligament was divided. He survived able to ambulate with a walking aid but lost most of the musculature of the anterior and peroneal compartments (Blaylock, 2003).

Reproductive

    3.20.1) SUMMARY
    A) Limited data are available regarding the effects of venom and antivenom on a human fetus. The risk of snake antivenom therapy in pregnancy is not available. Exposure may result in teratogenesis; mice and chicken embryos showed evidence of teratogenic effects after exposure to snake venom.
    B) In a series of 10 pregnant women, who were bitten by E. ocellatus in their 20th to 36th week of gestation, all patients survived with antivenom therapy and supportive care; fetal loss was reported in only one of the 10 patients.
    3.20.2) TERATOGENICITY
    A) LACK OF INFORMATION
    1) Limited data are available regarding the effects of venom and antivenom on a human fetus. Exposure may result in teratogenesis; mice and chicken embryos showed evidence of teratogenic effects after exposure to snake venom (Pantanowitz & Guidozzi, 1996).
    3.20.3) EFFECTS IN PREGNANCY
    A) LACK OF INFORMATION
    1) Limited data are available regarding the effects of venom and antivenom on a human fetus; the risk of snake antivenom therapy in pregnancy is not available. In general, antivenom is recommended in pregnant women with systemic or progressive local effects of envenomation, especially in cases of coagulopathy because of the increased risk of bleeding (e.g., disseminated intravascular coagulopathy) associated with a depression of the fibrinolytic system that occurs normally during pregnancy (Pantanowitz & Guidozzi, 1996).
    2) At the time of this review, it is unclear whether different types of venom, varying amounts of venom or routes of exposure have any effect on the developing fetus (Pantanowitz & Guidozzi, 1996).
    3) ANIMAL STUDIES
    a) In animal studies, the isolated rat uterus was exposed to B. arietans venom and developed both increased frequency and amplitude of uterine contractions (Pantanowitz & Guidozzi, 1996).
    B) STILLBIRTH
    1) CASE REPORT - Stillbirth was reported in a 17-year-old girl who was 24 weeks pregnant and was bitten by E.ocellatus (carpet viper). The patient presented 6 days post-envenomation with severe swelling, anemia, epistaxis, melena, and bleeding at the gums. There were no fetal heart sounds at presentation. With antivenom therapy and supportive care, the patient recovered. It is believed that the delay in presentation may have directly contributed to the resulting stillbirth (Habib et al, 2008).
    C) LACK OF EFFECT
    1) In a series of 10 pregnant women, who were bitten by E. ocellatus, in their 20th to 36th week of gestation, all patients survived with antivenom therapy and supportive care; fetal loss was reported in only one of the 10 patients. It is believed that delayed presentation by the patient (6 days post-envenomation) may have contributed to the outcome (Habib et al, 2008).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Monitor vital signs and mental status.
    B) Monitor for progression of edema, pain and lymphadenopathy.
    C) Mark leading edge of soft tissue swelling and measure circumference at the area of the bite, reassess for progression every 15 to 30 minutes.
    D) The following tests should be obtained upon admission and repeated every 6 hours to assess worsening envenomation and/or efficacy of antivenom:
    1) Obtain complete blood count with differential. Monitor coagulation studies including INR, PTT, fibrinogen, fibrin degradation products, and whole blood clotting time over 20 minutes if other tests are not available.
    2) Obtain serum electrolytes, renal function tests and urinalysis and repeated as needed.
    3) Culture wound if evidence of secondary infection is present.
    E) Caution should be used in all venipuncture studies due to the risk of bleeding and/or oozing that may occur at the site. Arterial punctures should be avoided when possible, particularly in incompressible sites.
    4.1.2) SERUM/BLOOD
    A) HEMATOLOGIC
    1) Obtain a complete blood count with differential. A coagulation profile which includes INR/PT and PTT, platelet count, fibrinogen level, and fibrin degradation products should be obtained after a viper envenomation. Repeat every 6 hours, or as indicated to assess for progression of envenomation or response to antivenom.
    B) BLOOD/SERUM CHEMISTRY
    1) Monitor blood urea nitrogen and creatinine as indicated.
    2) Obtain creatine kinase in patients with severe swelling or evidence of compartment syndrome.
    4.1.3) URINE
    A) URINALYSIS
    1) Obtain urinalysis. Monitor for evidence of bleeding (hematuria) or acute renal failure (proteinuria).
    4.1.4) OTHER
    A) OTHER
    1) CULTURES
    a) Obtain wound culture in necrotic wounds with suspected infection.

Methods

    A) SAMPLING
    1) WHOLE BLOOD CLOTTING TEST-If PT/INR and PT cannot be performed readily, a method to determine whole blood clotting can be done at the bedside with a few millimeters of venous blood placed in a new, clean, dry, glass tube (or bottle), if the patient has no history of coagulopathies. The steps are as follows and may be useful if the species is unknown or difficult to identify (Anon, 1999):
    1) Place a few millimeters of venous blood in a GLASS tube
    2) Leave undisturbed for 20 minutes at room temperature
    3) Tip the vessel once:
    a) If blood is still liquid and runs out it is indicative of a venom-induced coagulopathy.
    b) Inaccurate results may occur if the vessel had been cleaned previously with detergent. Incoagulable blood is more frequently associated with viper envenomations.
    a) FALSE NEGATIVE results could occur if clot identification is read beyond 20 minutes (Stone et al, 2006).
    b) FALSE POSITIVE results could occur if polypropylene or polyethylene tubes are used instead of glass (Stone et al, 2006).
    1) A blinded methodological study was conducted to determine the potential effectiveness of various plastic containers as compared to glass in performing the whole blood clotting time (WBCT) (for 20 minutes) in envenomed patients. An initial pilot study demonstrated that WBCT without venom was significantly different between glass and various plastic containers (ie, polypropylene, polyethylene and polycarbonate). Polypropylene and plain polyethylene were considered unsuitable for further testing because of their prolonged clotting times of greater than 60 minutes in the presence of venom. The findings further suggested that various venom concentrations (0 ng/mL to 100,000 ng/ml were initially tested) could significantly alter the clotting time. No clotting was observed in either the glass or polycarbonate tube for venom concentrations above 100 ng/mL. Samples of 0 ng/mL and 10 ng/mL were used in the study because they clotted in 20 minutes. Polycarbonate (mean time of 29.5 minutes in the presence of venom) was considered a suitable alternative to glass if the threshold for clot identification was increased to 35 minutes. However, the authors concluded that differentiating between various plastic materials may be difficult and polycarbonate tubes may not be readily available in all healthcare facilities; therefore, the authors recommended the continued use of glass tubes (Stone et al, 2006).
    a) LIMITATIONS - Although glass tubes have been found to be sensitive and specific indicators of severe coagulopathy, false negative results could occur if the test results are read beyond the 20 minute threshold time. Other potential limitations could include: measurement bias of clot size, container volumes were not standardized, and use of one venom type (Pseudechis australis) may influence extrapolation of findings to other venom types.
    c) If there is any doubt, repeat the test and include a "control" (blood from an unexposed individual) (Anon, 1999).
    B) IMMUNOASSAY
    1) The ELISA method has been used to identify specific venom and in blood, serum, urine, saliva, sputum, CSF and aspirates from a bite site, blisters and wounds (Pugh & Theakston, 1987).

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.6) DISPOSITION/BITE-STING EXPOSURE
    6.3.6.1) ADMISSION CRITERIA/BITE-STING
    A) Any patient who has been bitten by a proven or suspected venomous viper should be admitted to a hospital for a 24 hour observation period. Any patient with coagulopathy, hypotension, neurotoxicity, or airway compromise or who requires antivenom administration should be admitted to an intensive care setting.
    6.3.6.2) HOME CRITERIA/BITE-STING
    A) There should be NO home treatment for bites from proven or suspected venomous snakes. The goal of prehospital care is rapid transport to a healthcare facility.
    6.3.6.3) CONSULT CRITERIA/BITE-STING
    A) Consult a local herpetologist for proper identification of the snake if it is available. Consultation with a medical toxicologist or a toxinologist is strongly recommended with administration of antivenom. A local poison center can provide information on the appropriate antivenom and how to obtain it for bites by exotic species.
    B) Consult a local herpetologists for proper identification of the snake, if available.
    6.3.6.5) OBSERVATION CRITERIA/BITE-STING
    A) Any patient suspected of having been bitten by an African viper should be referred to healthcare facility and closely observed for a period of 24 hours.

Monitoring

    A) Monitor vital signs and mental status.
    B) Monitor for progression of edema, pain and lymphadenopathy.
    C) Mark leading edge of soft tissue swelling and measure circumference at the area of the bite, reassess for progression every 15 to 30 minutes.
    D) The following tests should be obtained upon admission and repeated every 6 hours to assess worsening envenomation and/or efficacy of antivenom:
    1) Obtain complete blood count with differential. Monitor coagulation studies including INR, PTT, fibrinogen, fibrin degradation products, and whole blood clotting time over 20 minutes if other tests are not available.
    2) Obtain serum electrolytes, renal function tests and urinalysis and repeated as needed.
    3) Culture wound if evidence of secondary infection is present.
    E) Caution should be used in all venipuncture studies due to the risk of bleeding and/or oozing that may occur at the site. Arterial punctures should be avoided when possible, particularly in incompressible sites.

Oral Exposure

    6.5.3) TREATMENT
    A) SUPPORT
    1) See the bite/stings section for detailed treatment information.

Enhanced Elimination

    A) PLASMAPHERESIS
    1) CASE REPORT: A 27-year-old man developed hemolysis, thrombocytopenia, and acute renal failure following envenomation from Proatheris superciliaris. Daily plasmapheresis treatments over a total of 7 days resulted in apparent clinical improvement of the patient, although renal laboratory parameters remained elevated and there was only marginal improvement in hematologic function. The authors question whether plasmapheresis was directly responsible for the patient's recovery (Keyler, 2008).

Summary

    A) TOXICITY: An estimated 20% to 50% of snake bites result in no actual envenomation - "dry bite". In general, fatalities are more common in children than adults. Fatalities have been reported among the genus Bitis with most reported among B. arietans. Infrequent to rare reports of fatalities have also occurred following the envenomation by the genus Echis (E. coloratus, E. ocellatus, and E. pyramidum considered the most common cause of fatal snakebite in the Sudan) and the genus Vipera (V. latasti, V. macrovipera lebetina, and V. palaestinae).

Minimum Lethal Exposure

    A) SUMMARY
    1) The following species have resulted in fatal envenomations:
    a) Genus Bitis:
    1) B. arietans (puff adder) - fatalities among these species are infrequent.
    2) B. atropos (berg adder) - rare reports of deaths.
    b) Genus Causus:
    1) At the time of this review, no deaths reported.
    c) Genus Cerastes:
    1) At the time of this review, several deaths have been reported following envenomation by Cerastes Cerastes species.
    d) Genus Echis:
    1) E. carinatus - infrequent reports of fatalities.
    2) E. coloratus (Burton's carpet viper) - infrequent reports of fatalities.
    3) E. ocellatus (carpet viper) - deaths have been reported; relatively high rates of mortality (10%-20%) and morbidity in rural communities of the savanna region of West Africa, including Nigeria.
    4) E. pyramidum {Egyptian carpet viper} - considered the most common cause of fatal snakebite in the Sudan.
    e) Genus Vipera:
    1) Fatalities have been reported from V. latasti (rare cares) and V. palaestinae (secondary to systemic hemorrhage). No cases of fatalities have been reported from Bornmueller's viper (V. bornmuelleri).
    f) References: (Rebahi et al, 2014; Pugh & Theakston, 1987; Laing et al, 1995; Warrell, 1995)
    B) CASE REPORTS
    1) CERASTES CERASTES: A 32-year-old woman was bitten by a horned viper on her hand and the following day developed tonic-clonic seizures. Upon admission she had a Glasgow Coma Scale score of 12 and spontaneous bleeding of the gums. Her CNS function further declined (GCS 8) and she was electively intubated and ventilated. Two days after envenomation, a CT of the brain showed an extensive infarction of the brain including frontal, temporal, and parietal lobes with cerebral edema. She also had laboratory evidence of disseminated intravascular coagulation. Despite supportive care, her CNS function did not improve and she died (Rebahi et al, 2014).
    2) CERASTES CERASTES: A 5-year-old girl was hospitalized with confusion, polypnea, and compartment syndrome in her lower limb 4 days after being bitten by a C. cerastes viper. She required immediate intubation and ventilation. Coagulation studies were abnormal. A CT scan of the brain showed an extensive frontal-parieto-occipital ischemic stroke. Although she received supportive care, her neurologic function continued to decline and she died on day 7 (Rebahi et al, 2014).

Maximum Tolerated Exposure

    A) SUMMARY
    1) A snake bite does not always indicate that envenomation has occurred (Warrell, 1995).
    2) Local tissue injury can include immediate, severe pain, moderate local and regional swelling, and tissue necrosis. Surgical debridement may be required in some cases (Warrell, 1995).
    3) B. arietans (puff adder): Compartment syndrome, resulting in bilateral carpal tunnel release, was reported in a 16-year-old female after receiving a bite by a puff adder (Schweitzer & Lewis, 1981). Compartment syndrome has been reported in 2 patients bitten by C. cerastes (Desert horned or Egyptian sand vipers) (Rebahi et al, 2014).
    4) Cerastes vipera and C. cerastes envenomations have produced disseminated intravascular coagulation (Lifshitz et al, 2000; Rebahi et al, 2014).
    5) Although not frequently reported, neurotoxicity has been observed after envenomations by the B. atropos (berg adder) and the E. pyramidum (Egyptian carpet viper), and neurotoxin venom has been found in the venoms of the B. caudalis (horned adder) and the B. atropos (berg adder). The V. palaestinae (Palestine viper) contains a neurotoxic polypeptide that can act directly on the medulla (Warrell, 1995).
    B) CASE REPORTS
    1) CERASTES CERASTES: A 51-year-old man was bitten by a C. cerastes viper and early on developed compartment syndrome of his right limb, hemodynamic shock, rhabdomyolysis and hyperkalemia. He also had evidence of DIC. A fasciotomy was performed and 48 hours later his neurologic function declined and his Glasgow Coma Scale score dropped to 10. A CT scan of brain showed acute bilateral cerebral infarctions in internal capsules. He was intubated and ventilated and successfully extubated on day 7. He gradually recovered and his neurologic function was normal at 3 months (Rebahi et al, 2014).

Toxicity Information

    7.7.1) TOXICITY VALUES
    A) LD50- (INTRAMUSCULAR)MOUSE:
    1) 2 mg/kg (RTECS, 2001)
    B) LD50- (INTRAPERITONEAL)MOUSE:
    1) 560 mcg/kg (RTECS, 2001)
    C) LD50- (SUBCUTANEOUS)MOUSE:
    1) 600 mcg/kg (RTECS, 2001)
    D) LD50- (INTRAPERITONEAL)MOUSE:
    1) 180 mcg/kg (RTECS, 2001)
    E) LD50- (INTRAMUSCULAR)MOUSE:
    1) 5200 mcg/kg (RTECS, 2001)
    F) LD50- (INTRAPERITONEAL)MOUSE:
    1) 720 mcg/kg (RTECS, 2001)
    G) LD50- (SUBCUTANEOUS)MOUSE:
    1) 5 mg/kg (RTECS, 2001)
    H) LD50- (INTRAMUSCULAR)MOUSE:
    1) 8600 mcg/kg (RTECS, 2001)
    I) LD50- (INTRAPERITONEAL)MOUSE:
    1) 296 mcg/kg (RTECS, 2001)
    J) LD50- (SUBCUTANEOUS)MOUSE:
    1) 475 mcg/kg (RTECS, 2001)
    K) LD50- (INTRAPERITONEAL)MOUSE:
    1) 250 mcg/kg (RTECS, 2001)
    L) LD50- (INTRAPERITONEAL)MOUSE:
    1) 376 mcg/kg (RTECS, 2001)
    M) LD50- (SUBCUTANEOUS)MOUSE:
    1) 5167 mcg/kg (RTECS, 2001)
    N) LD50- (INTRAPERITONEAL)MOUSE:
    1) 1920 mcg/kg (RTECS, 2001)
    O) LD50- (SUBCUTANEOUS)MOUSE:
    1) 6250 mcg/kg (RTECS, 2001)
    P) LD50- (INTRAMUSCULAR)MOUSE:
    1) 10 mg/kg (RTECS, 2001)
    Q) LD50- (INTRAPERITONEAL)MOUSE:
    1) 6600 mcg/kg (RTECS, 2001)
    R) LD50- (SUBCUTANEOUS)MOUSE:
    1) 2720 mcg/kg (RTECS, 2001)
    S) LD50- (INTRAMUSCULAR)RAT:
    1) >1500 mcg/kg (RTECS, 2001)
    T) LD50- (INTRAPERITONEAL)RAT:
    1) 1330 mcg/kg (RTECS, 2001)
    U) LD50- (INTRAPERITONEAL)MOUSE:
    1) 1900 mcg/kg (RTECS, 2001)

Toxicologic Mechanism

    A) TISSUE NECROSIS is attributable to abundant proteolytic enzymes and phospholipases A2 that are present in viper venom (Warrell, 1995).
    B) CARDIOVASCULAR EFFECTS - Viper venom can produce a decline in blood pressure by increasing vascular permeability leading to hypovolemia; some species (i.e., B. gabonica, B. arietans) can have a direct effect on the heart and other species (i.e., B. arietans) can produce splanchnic vasodilatation, and autopharmacological release of vasodilators such as bradykinin can occur in some species (e.g., V. palaestinae) (Warrell, 1995).
    C) NEUROTOXICITY may occur in some species and has been associated with the berg adder (B. atropos) and E. pyramidum species. PLA2 neurotoxins have been found in the B. caudalis (horned adder) and the B. atropos (puff adder). The V. Palestine (Palestine viper) has a neurotoxic polypeptide "vipertoxin" which can cause circulatory failure by acting on the medullary center (Warrell, 1995).
    D) HEMOSTATIC TOXICITY - Several species are responsible for producing hematological disturbances (Warrell, 1995):
    1) B. arietans (puff adder) has botrocetin-like activity which can cause platelet aggregation and hemorrhagin activity;
    2) B. gabonica (gaboon viper) has fibrinogen clotting activity which can split off fibrinopeptides A and B from fibrinogen, has direct fibrinogenolytic activity, and hemorrhagin activity;
    3) Cerastes Cerastes (horned or desert viper) activates Factor X and has direct fibrinogenolytic activity;
    4) C. rhombeatus - procoagulant activity, also contains a serine protease which inactivates antithrombin III and hemorrhagin activity;
    5) Echis carinatus (carpet viper) activates prothrombin and Factor X, direct fibrinogenolytic activity, inhibits platelet activation, contains a fibrinogenolysin and contains hemorrhagins (i.e., zinc metalloproteinase) that can damage vascular endothelium;
    6) E. coloratus (white-bellied carpet viper) activates Factor X and hemorrhagin activity;
    7) E. sochureki (Sochurek's saw-scaled viper) activates protein C;
    8) Psuedocerastes persicus (false-horned viper) - procoagulant activity.

General Bibliography

    1) Aissaoui Y, Hammi S, Chkoura K, et al: [Association of ischemic and hemorrhagic cerebral stroke due to severe envenomation by the Sahara horned viper (Cerastes cerastes)]. Bull Soc Pathol Exot 2013; 106(3):163-166.
    2) American Zoo and Aquarium Association: Antivenom Index. American Zoo and Aquarium Association. Silver Spring, MD. 2009. Available from URL: http://www.aza.org/ai/index.cfm. As accessed 2009-04-13.
    3) Anon: WHO/SEARO guidelines for clinical management of snake bites. So Asian J Trop Med Pub Health 1999; 30 (S1):1-85.
    4) Bey TA, Boyer LV, & Walter FG: Exotic snakebite: envenomation by an African puff adder (bitis arietans). J Emerg Med 1997; 15:827-831.
    5) Blaylock RS: Femoral vessel entrapment and compartment syndromes following snakebite. S African J Surg 2003; 41(3):72-74.
    6) Boyer DM: Antivenom Index, The American Zoo and Aquarium Association and The American Association of Poison Control Centers, AZA Antivenom Index Editor, Department of Herpetology, San Diego Zoo, San Diego, CA, 1999.
    7) Chen JC, Liaw SJ, & Bullard MJ: Treatment of poisonous snakebites in northern Taiwan. J Formos Med Assoc 2000; 99:135-139.
    8) Chippaux JP, Lang J, & Amadi Eddine S: Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. Trans Roy Soc Trop Med Hyg 1998; 92:657-662.
    9) Chippaux JP, Massougbodji A, Stock RP, et al: Clinical trial of an F(ab')2 polyvalent equine antivenom for African snake bites in Benin. Am J Trop Med Hyg 2007; 77(3):538-546.
    10) Christensen PA: Snakebite and the use of antivenom in southern Africa. S Afr Med J 1981; 59:934-938.
    11) Einterz EM & Bates ME: Snakebite in northern Cameroon: 134 victims of bites by the saw-scaled or carpet viper, Echis ocellatus. Trans R Soc Trop Med Hyg 2003; 97(6):693-696.
    12) Gillissen A, Theakston RDG, & Barth J: Neurotoxicity, haemostatic disturbances and haemolytic anaemia after a bite by a Tunisian saw-scaled or carpet viper (Echis 'pyramidum' - complex): failure of antivenom treatment. Toxicon 1994; 32:937-944.
    13) Gocmen B, Arikan H, Ozbel Y, et al: Clinical, physiological and serological observations of a human following a venomous bite by Macrovipera lebetina lebetina (Reptilia: Serpentes). Turkiye.Parazitol.Derg. 2006; 30(2):158-162.
    14) Gutierrez JM, Rojas E, Quesada L, et al: Pan-african polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa. Transact Roy Soc Trop Med 2005; 99:468-475.
    15) Habib AG , Abubakar SB , Abubakar IS , et al: Envenoming after carpet viper (Echis ocellatus) bite during pregnancy: timely use of effective antivenom improves maternal and foetal outcomes. Trop Med Int Health 2008; 13(9):1172-1175.
    16) Halkin A , Jaffe R , Mevorach D , et al: Thoracic complications following snake envenomization. Am J Med 1997; 102(6):585-587.
    17) Hantson P, Verhelst D, Wittebole X, et al: Defibrination and systemic bleeding caused by an imported African snakebite. European J Emerg Med 2003; 10:349-352.
    18) Hurrell DP: Namaqua dwarf adder bite. S Afr Med J 1981; 59:491-492.
    19) Keyler DE: Envenomation by the lowland viper (Proatheris superciliaris): severe case profile documentation. Toxicon 2008; 52(8):836-841.
    20) Kleinman ME, Chameides L, Schexnayder SM, et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 14: pediatric advanced life support. Circulation 2010; 122(18 Suppl.3):S876-S908.
    21) Laing GD, Harrison RA, Theakston RDG, et al: Polyspecific snake antivenom may help in antivenom crisis (letter). BMJ 2003; 326:447-448.
    22) Laing GD, Lee L, & Smith DC: Experimental assessment of a new, low-cost antivenom for treatment of carpet viper (Echis ocellatus) envenoming. Toxicon 1995; 33:307-313.
    23) Lieberman P, Nicklas R, Randolph C, et al: Anaphylaxis-a practice parameter update 2015. Ann Allergy Asthma Immunol 2015; 115(5):341-384.
    24) Lieberman P, Nicklas RA, Oppenheimer J, et al: The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126(3):477-480.
    25) Lifshitz M, Kapelushnik J, Ben-Harosh M, et al: Disseminated intravascular coagulation after cerastes vipera envenomation in a 3-year-old child: a case report. Toxicon 2000; 38(11):1593-1598.
    26) Marsh N, DeRoos F, & Touger M: Gaboon viper (Bitis gabonica) envenomation resulting from captive specimens--a review of five cases. Clin Toxicol (Phila) 2007; 45(1):60-64.
    27) Mebs D , Holada K , Kornalik F , et al: Severe coagulopathy after a bite of a green bush viper (Atheris squamiger): case report and biochemical analysis of the venom. Toxicon 1998; 36(10):1333-1340.
    28) Meier J & White J: Handbook of Clinical Toxicology and Animal Venoms and Poisons, CRC Press, Boca Raton, FL, 1995a.
    29) Meier J & White J: Handbook of Clinical Toxicology of Animal Venoms and Poisons, CRC Press, Inc, Boca Raton, FL, 1995, pp 110-111.
    30) Meyer WP, Habib AG, & Onayade AA: First clinical experience with a new ovine fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with institute Pasteur serum (Ipser) Africa antivenom. Am J Trop Med Hyg 1997; 56:291-300.
    31) Munday SW, Williams SR, & Clark RF: Dendrotoxin poisoning in a neurobiochemist. J Toxicol Clin Toxicol 2003; 41(2):163-165.
    32) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    33) Nowak RM & Macias CG : Anaphylaxis on the other front line: perspectives from the emergency department. Am J Med 2014; 127(1 Suppl):S34-S44.
    34) Pantanowitz L & Guidozzi F: Management of snake and spider bite in pregnancy. Obstet Gynecol Surv 1996; 51:615-620.
    35) Peberdy MA , Callaway CW , Neumar RW , et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care science. Part 9: post–cardiac arrest care. Circulation 2010; 122(18 Suppl 3):S768-S786.
    36) Product Information: diphenhydramine HCl intravenous injection solution, intramuscular injection solution, diphenhydramine HCl intravenous injection solution, intramuscular injection solution. Hospira, Inc. (per DailyMed), Lake Forest, IL, 2013.
    37) Product Information: dopamine hcl, 5% dextrose IV injection, dopamine hcl, 5% dextrose IV injection. Hospira,Inc, Lake Forest, IL, 2004.
    38) Product Information: norepinephrine bitartrate injection, norepinephrine bitartrate injection. Sicor Pharmaceuticals,Inc, Irvine, CA, 2005.
    39) Pugh RNH & Theakston RDG: A clinical study of viper bite poisoning. Ann Trop Med Parasitol 1987; 81:135-149.
    40) Rainer PP, Kaufmann P, Smolle-Juettner FM, et al: Case report: Hyperbaric oxygen in the treatment of puff adder (Bitis arietans) bite. Undersea Hyperb Med 2010; 37(6):395-398.
    41) Rebahi H, Nejmi H, Abouelhassan T, et al: Severe envenomation by Cerastes cerastes viper: an unusual mechanism of acute ischemic stroke. J Stroke Cerebrovasc Dis 2014; 23(1):169-172.
    42) Schweitzer G & Lewis JS: Puff adder bite - an unusual cause of bilateral carpal tunnel syndrome. S Afr Med J 1981; 60:714-715.
    43) Sharma LEKHR, Lal VIVEK, & Simpson IAND: Snakes of medical significance in India: the first reported case of envenoming by the Levantine viper (Macrovipera lebetina). Wilderness Environ Med 2008; 19(3):195-198.
    44) Stone R, Seymour J, & Marshall O: Plastic containers and the whole-blood clotting test: glass remains the best option. Trans R Soc Trop Med Hyg 2006; 100(12):1168-1172.
    45) Tekin R, Sula B, Cakir G, et al: Comparison of snakebite cases in children and adults. Eur Rev Med Pharmacol Sci 2015; 19(14):2711-2716.
    46) Top lJ, Tulleken JE, Ligtenberg JJ, et al: Serious envenomation after a snakebite by a Western bush viper (Atheris chlorechis) in the Netherlands: a case report. Neth J Med 2006; 64(5):153-156.
    47) US Navy: Poisonous Snakes of the World, US Govt Printing Office, Washington, DC, 1965.
    48) USDN: Poisonous Snakes of the World. U.S, Dover Publications, Inc, New York, NY, 1991.
    49) Valenta J, Stach Z, Fricova D, et al: Envenoming by the viperid snake Proatheris superciliaris: a case report. Toxicon 2008; 52(2):392-394.
    50) Vanden Hoek,TL; Morrison LJ; Shuster M; et al: Part 12: Cardiac Arrest in Special Situations 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. American Heart Association. Dallas, TX. 2010. Available from URL: http://circ.ahajournals.org/cgi/reprint/122/18_suppl_3/S829. As accessed 2010-10-21.
    51) Visser LE, Kyei-Faried S, Belcher DW, et al: Failure of a new antivenom to treat echis ocellatus snake bite in rural Ghana: the importance of quality surveillance. Trans R Soc Trop Med Hyg 2008; 102(5):445-450.
    52) Warrell DA: Bites by exotic elapidae, in Boyer DM (ed): Antivenom Index, American Zoo and Aquarium Association and American Association of Poison Control Centers, San Diego, CA, 1999, pp 91-99.
    53) Warrell DA: Clinical toxicology of snakebites in Africa and the middle east/Arabian peninsula, in Meier J & White J (eds): Handbook of Clinical Toxicology of Animal Venoms and Poisons, CRC Press, Boca Raton, FL, 1995, pp 433-492.